We have located links that may give you full text access.
Effects of Mother Voice on Physiological Response and Motor Nerve Development of Newborns with Maternal Separation Under the New Epidemic Situation.
Alternative Therapies in Health and Medicine 2024 March 23
OBJECTIVE: To investigate an alternative approach to family participatory nursing in neonatal intensive care units (NICUs) during the COVID-19 pandemic, focusing on auditory interventions to mitigate the effects of maternal separation (MS) on neonatal neurological development.
METHODS: This study was a randomized, double-blind, prospective trial involving 100 newborns younger than 6 months old, born between January 2022 and October 2022, who experienced MS for more than 2 weeks. Newborns were randomly allocated into control and study groups using a computer-generated list to ensure unbiased selection. Inclusion criteria were gestational age ≥37 weeks and admission to NICU due to various medical conditions; exclusion criteria included severe hearing impairment and congenital neurological disorders. The intervention group received maternal voice exposure at 40-50 dB for eight 30-minute sessions daily, while the control group was exposed to children's songs at the same volume and duration. Key metrics such as oxygen saturation, heart rate, Neonatal Infant Pain Scale (NIPS) scores, and Neonatal Behavioral Neurological Assessment (NBNA) scores were measured before and after the intervention period, which lasted one week.
RESULTS: Post-intervention, the NIPS scores in the intervention group were significantly lower (3.45±0.99) compared to the control group (5.36±0.49, P < .01), indicating reduced pain sensitivity. Additionally, NBNA scores were higher in the intervention group (39.90±1.56) than in the control group (35.86±1.05, P < .01), suggesting enhanced neurological development. No significant difference in pre-intervention blood oxygen saturation levels was observed between the groups. However, the intervention group showed less reduction in oxygen saturation during and post-blood collection, with significantly higher levels at 2, 4, and 6 minutes post-procedure (P < .01). The findings underscore the significance of maternal voice as a non-pharmacological intervention to alleviate pain and foster neurological development in neonates facing MS, especially in situations where traditional family participatory nursing is hindered by the COVID-19 pandemic. Integrating maternal voice stimulation into neonatal care strategies offers a viable method to improve outcomes for newborns undergoing MS.
CONCLUSION: Maternal voice intervention presents a promising strategy to diminish pain sensitivity and bolster neurological development in neonates separated from their mothers, particularly when family participatory nursing practices are constrained by pandemic-related restrictions. These findings advocate for the broader implementation of maternal voice stimulation in NICU settings.
METHODS: This study was a randomized, double-blind, prospective trial involving 100 newborns younger than 6 months old, born between January 2022 and October 2022, who experienced MS for more than 2 weeks. Newborns were randomly allocated into control and study groups using a computer-generated list to ensure unbiased selection. Inclusion criteria were gestational age ≥37 weeks and admission to NICU due to various medical conditions; exclusion criteria included severe hearing impairment and congenital neurological disorders. The intervention group received maternal voice exposure at 40-50 dB for eight 30-minute sessions daily, while the control group was exposed to children's songs at the same volume and duration. Key metrics such as oxygen saturation, heart rate, Neonatal Infant Pain Scale (NIPS) scores, and Neonatal Behavioral Neurological Assessment (NBNA) scores were measured before and after the intervention period, which lasted one week.
RESULTS: Post-intervention, the NIPS scores in the intervention group were significantly lower (3.45±0.99) compared to the control group (5.36±0.49, P < .01), indicating reduced pain sensitivity. Additionally, NBNA scores were higher in the intervention group (39.90±1.56) than in the control group (35.86±1.05, P < .01), suggesting enhanced neurological development. No significant difference in pre-intervention blood oxygen saturation levels was observed between the groups. However, the intervention group showed less reduction in oxygen saturation during and post-blood collection, with significantly higher levels at 2, 4, and 6 minutes post-procedure (P < .01). The findings underscore the significance of maternal voice as a non-pharmacological intervention to alleviate pain and foster neurological development in neonates facing MS, especially in situations where traditional family participatory nursing is hindered by the COVID-19 pandemic. Integrating maternal voice stimulation into neonatal care strategies offers a viable method to improve outcomes for newborns undergoing MS.
CONCLUSION: Maternal voice intervention presents a promising strategy to diminish pain sensitivity and bolster neurological development in neonates separated from their mothers, particularly when family participatory nursing practices are constrained by pandemic-related restrictions. These findings advocate for the broader implementation of maternal voice stimulation in NICU settings.
Full text links
Related Resources
Trending Papers
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Prevention and treatment of ischaemic and haemorrhagic stroke in people with diabetes mellitus: a focus on glucose control and comorbidities.Diabetologia 2024 April 17
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Eosinophilic Esophagitis: Clinical Pearls for Primary Care Providers and Gastroenterologists.Mayo Clinic Proceedings 2024 April
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app